Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Banking & Finance  -  Page 163

Montecito Bank & Trust
Latest

The Trade Desk increases share price range for IPO

By   /  Monday, September 19th, 2016  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on The Trade Desk increases share price range for IPO

Ventura-based digital marketing firm The Trade Desk increased the price range it expects to sell its shares for when the company holds its initial public offering. In documents filed with the Securities and Exchange Commission Sept. 22, The Trade Desk increased its pricing point to between $16 and $18 per share and expects to sell Read More →

Read More →
Latest

QAD announces quarterly dividend

By   /  Thursday, September 15th, 2016  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on QAD announces quarterly dividend

QAD announced a quarterly dividend of 7.2 cents per share for Class A common stock and 6 cents per share for Class B common stock on Sept. 15. QAD has declared the same dividend for 13 of the past 14 quarters. Headed by QAD President and Chairman Pamela Lopker and her husband and CEO Karl Read More →

Read More →
Latest

Resonant plans to raise $9.2 million in public offering

By   /  Friday, September 9th, 2016  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Resonant plans to raise $9.2 million in public offering

Resonant, a late stage Goleta development company designing small smartphone technology, plans to raise $9.2 million in a public offering. Documents filed with the Securities and Exchange Commission Sept. 9 said the company plans to offer about 2.4 million shares for $4.25 per share. The company expects to complete the offering by Sept. 14. Resonant Read More →

Read More →
Latest

Mission Wealth Management launches Social Values Portfolio

By   /  Wednesday, September 7th, 2016  /  Latest news, Personal Finance  /  Comments Off on Mission Wealth Management launches Social Values Portfolio

Santa Barbara-based financial advising firm Mission Wealth Management launched its new Social Values Portfolio, which aligns investments with an investor’s values. “The introduction of the Social Values Portfolio is in perfect alignment with Mission Wealth’s purpose as a business to serve both our clients and the community at large,” Mission Wealth CEO and founder Seth Streeter Read More →

Read More →
Latest

Greed drives skyrocketing cost of drugs in the U.S.

By   /  Friday, September 2nd, 2016  /  Columns, Latest news, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Greed drives skyrocketing cost of drugs in the U.S.

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Fiscal reform needed as pension time bomb ticks away

By   /  Friday, September 2nd, 2016  /  Banking & Finance, Banking Industry, Columns, Latest news, Top Stories, Tri-County Economy  /  Comments Off on Fiscal reform needed as pension time bomb ticks away

America’s summer of fiscal discontent is coming to a close on a downbeat note. The California legislature is preparing to wind up its session having stirred up a lot of controversy but done almost nothing to address the state’s ongoing pension crisis. The burgeoning shortfall now adds up to $139 billion in the CalPERS fund Read More →

Read More →
Latest

FDA approves Amgen’s Blincyto

By   /  Thursday, September 1st, 2016  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on FDA approves Amgen’s Blincyto

The U.S. Food and Drug Administration approved Amgen’s drug Blincyto for treating pediatric leukemia patients Sept. 1. In Dec. 2014, the FDA approved Blincyto to treat patients with precursor B-cell acute lymphoblastic leukemia, which is a rare form of the disease. On Sept. 1, the agency extended Blincyto’s approval to include pediatric patients with another Read More →

Read More →